Article info
PDFConcise reports
Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor β levels in rheumatoid arthritis
- Correspondence to:
Professor J Kekow, Clinic of Rheumatology, University of Magdeburg, D-39245 Vogelsang/Magdeburg, Germany;
joern.kekow{at}medizin.uni-magdeburg.de
Citation
Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor β levels in rheumatoid arthritis
Publication history
- Accepted September 4, 2001
- First published March 1, 2002.
Online issue publication
January 09, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Annals of the Rheumatic Diseases